Integrating Peptide Therapy into Modern Aesthetic Practices

We are seeing a significant shift in patient expectations as they move beyond surface-level injectables toward systemic longevity protocols. Incorporating peptide therapy into our clinics allows us to address cellular repair and growth hormone optimization through compounds like BPC-157, CJC-1295, and Ipamorelin. From an operational standpoint, these treatments create a recurring revenue model that complements traditional aesthetic cycles. We have found that BPC-157 is particularly effective when positioned for soft tissue recovery, while the combination of CJC-1295 and Ipamorelin supports metabolic health and skin quality from the inside out. As operators, we must ensure strict compounding pharmacy oversight to maintain product purity and regulatory compliance. This clinical expansion requires thorough staff training on subcutaneous injection protocols and contraindications. By layering these therapies into our existing service menus, we provide a more holistic approach to anti-aging that keeps patients engaged between their neurotoxin appointments and improves overall long-term outcomes.